文献速递关节外科骨肿瘤

血液系统恶性肿瘤与全髋关节置换术后不良围手术期结局相关

Hematologic Malignancies Are Associated With Adverse Perioperative Outcomes After Total Hip Arthroplasty.
PubMed 文献 · J Arthroplasty · 2017-03-11

基于美国全国住院患者样本2000至2011年2864412例全髋关节置换术患者,其中18012例合并血液系统恶性肿瘤,倾向性匹配后比较17810例恶性肿瘤患者与17888例对照。血液系统恶性肿瘤增加手术相关并发症(OR 1.4,P<.0001)和一般内科并发症(OR 1.47,P<.0001)风险,并延长住院时间(0.16天,P=.004)和增加费用(1101美元,P<.0001)。

要点

  • 合并血液系统恶性肿瘤的全髋关节置换患者手术相关并发症风险升高(OR 1.4,P<.0001)。
  • 一般内科并发症风险亦升高(OR 1.47,P<.0001)。
  • 住院时间延长0.16天(P=.004),费用增加1101美元(P<.0001)。

核心结论

  • 合并血液系统恶性肿瘤的全髋关节置换患者围手术期并发症风险增加、住院时间更长且费用更高。
  • 针对该类人群不良围手术期结局的风险量化及费用增加,可能有助于设计不同的风险分层和支付方式。

研究设计与样本

  • 基于美国全国住院患者样本(Nationwide Inpatient Sample)识别2000至2011年接受全髋关节置换术的患者共2864412例。
  • 其中诊断为任何血液系统恶性肿瘤的患者18012例,进一步分层为霍奇金病786例、非霍奇金淋巴瘤5062例、浆细胞病2067例、白血病5644例、骨髓增殖性肿瘤3552例和骨髓增生异常综合征1082例。
  • 对人口学特征、医院特征和合并症进行倾向性匹配,得到任何血液系统恶性肿瘤患者17810例和对照17888例,并对恶性肿瘤亚型与对照进行额外匹配。
  • 采用多变量回归分析手术和内科并发症、住院时间及费用。

主要发现

  • 与对照相比,血液系统恶性肿瘤增加任何手术相关并发症风险(OR 1.4,P<.0001)。
  • 与对照相比,血液系统恶性肿瘤增加任何一般内科并发症风险(OR 1.47,P<.0001)。
  • 血液系统恶性肿瘤与住院时间增加0.16天相关(P=.004)。
  • 血液系统恶性肿瘤与费用增加1101美元相关(P<.0001)。

临床怎么用

  • 原文结论未给出具体临床推荐,仅指出风险量化及费用增加可能有助于设计风险分层和支付方式。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Advancements in treating hematologic malignancies have improved survival, and these patients may be part of the growing population undergoing total hip arthroplasty (THA). Therefore, the purpose of this study was to evaluate the perioperative outcomes of THA in patients with hematologic malignancies. METHODS: The Nationwide Inpatient Sample identified patients who underwent THA from 2000 to 2011 (n = 2,864,412). Patients diagnosed with any hematologic malignancy (n = 18,012) were further stratified into Hodgkin disease (n = 786), non-Hodgkin lymphoma (n = 5062), plasma cell dyscrasias (n = 2067), leukemia (n = 5644), myeloproliferative neoplasms (n = 3552), and myelodysplastic syndromes (n = 1082). Propensity matching for demographics, hospital characteristics, and comorbidities identified 17,810 patients with any hematologic malignancy and 17,888 controls; additional matching was performed to compare hematologic malignancy subtypes with controls. Multivariate regression was used to analyze surgical and medical complications, length of stay (LOS), and costs. RESULTS: Compared to controls, hematologic malignancies increased the risk of any surgery-related complication (odds ratio [OR], 1.4; P < .0001) and any general medical complication (OR, 1.47; P < .0001). Additionally, hematologic malignancies were associated with an increase in LOS (0.16 days; P = .004) and increased costs ($1,101; P < .0001). CONCLUSION: Patients with hematologic malignancies undergoing THA have an increased risk of perioperative complications, longer LOS, and higher costs. The risk quantification for adverse perioperative outcomes in association with increased cost may help to design different risk stratification and reimbursement methods in such populations.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Newman JM, George J, North WT, et al. Hematologic Malignancies Are Associated With Adverse Perioperative Outcomes After Total Hip Arthroplasty. J Arthroplasty. 2017. PMID: 28372919. doi:10.1016/j.arth.2017.03.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。